1,148
Participants
Start Date
June 9, 2016
Primary Completion Date
December 30, 2022
Study Completion Date
December 30, 2022
Esketamine Nasal Spray
Open-Label Induction Phase: Participants will self-administer with esketamine nasal spray twice per week for 4 weeks as a flexible dose regimen (56 milligram \[mg\] or 84 mg for those \< 65 years; 28 mg, 56 mg or 84 mg for those \>= 65 years). Participants \>= 65 years old will start at a dose of 28 mg on Day 1. Optimization/Maintenance Phase: Participants entering from studies ESKETINTRD3001 (NCT02417064), ESKETINTRD3002 (NCT02418585) or ESKETINTRD3006 (US sites only) will self-administer esketamine nasal spray (same dose) once weekly. Participants entering from study ESKETINTRD3005 (NCT02422186) will self-administer esketamine nasal spray (28 mg in week 1; 28 or 56 mg in week 2; and 28, 56 or 84 mg in week 3 and 4) once weekly. After Week 4 (starting at Week 5), based on the Investigator's clinical judgment, the dose of esketamine for all participants can be adjusted based upon efficacy and tolerability.
Birmingham
Little Rock
Garden Grove
Glendale
Oakland
Orange
San Diego
San Rafael
Hartford
New Haven
Gainesville
Miami
Orlando
Atlanta
Chicago
Hoffman Estates
Joliet
Maywood
Skokie
Iowa City
Wichita
Lake Charles
Shreveport
Baltimore
Gaithersburg
Boston
New Bedford
Watertown
Worcester
Rochester Hills
O'Fallon
Saint Charles
Omaha
Cedarhurst
New York
Staten Island
Hickory
Cincinnati
Oklahoma City
Allentown
Media
Philadelphia
Lincoln
Providence
Charleston
Austin
Dallas
Houston
Wichita Falls
Charlottesville
Waukesha
Banfield
Buenos Aires
Córdoba
La Plata
Mendoza
Rosario
Caulfield
Elizabeth Vale
Frankston
Vienna
Aalst
Bruges
Brussels
Heusden-Zolder
Liège
Yvoir
Belo Horizonte
Curitiba
Fortaleza
Passo Fundo
Porto Alegre
Recife
Rio de Janeiro
São Bernardo do Campo
São Paulo
Burgas
Kardzhali
Pazardzhik
Pleven
Plovdiv
Rousse
Sofia
Varna
Vancouver
Kingston
Ottawa
Toronto
Brno
Pilsen
Prague
Tallinn
Tartu
Kuopio
Clermont-Ferrand
Douai
Nantes
Nîmes
Paris
Poitiers
Toulon
Berlin
Bochum
Mainz
Mittweida
Oranienburg
Pfaffenhofen
Budapest
Debrecen
Győr
Pécs
Sopron
Szekszárd
Vác
Kaunas
Kuala Lumpur
Guadalajara
León
Mexico City
México
Monterrey
San Luis Potosí City
Bełchatów
Bialystok
Bydgoszcz
Gdansk
Leszno
Lublin
Warsaw
Bratislava
Liptovský Mikuláš
Rimavská Sobota
Rožňava
Svidník
Cape Town
Pretoria
Welgemoed
Gwangju
Seoul
Alcorcón
Barcelona
Bilbao
Madrid
Oviedo
Palma
Pamplona
Sabadell
Salamanca
Sant Boi de Llobregat
Torrevieja
Vitoria-Gasteiz
Zamora
Halmstad
Lund
Skövde
Stockholm
Kaohsiung City
New Taipei City
Taichung
Taipei
Taoyuan District
Adana
Ankara
Bursa
Istanbul
Kucukcekmece/Istanbul
Oanakkale
Samsun
Chesterfield
Derby
London
Northampton
Oxford
Janssen Research & Development, LLC
INDUSTRY